Review: taking Cetirizine hydrochloride allergy and Intuniv together


Summary

Drug interactions are reported among people who take Cetirizine hydrochloride allergy and Intuniv together. This review analyzes the effectiveness and drug interactions between Cetirizine hydrochloride allergy and Intuniv. It is created by eHealthMe based on reports of 47 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Cetirizine hydrochloride allergy and Intuniv >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cetirizine Hydrochloride Allergy

Cetirizine hydrochloride allergy has active ingredients of cetirizine. It is often used in allergies. (latest outcomes from Cetirizine hydrochloride allergy 447 users)

Intuniv

Intuniv has active ingredients of guanfacine. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Intuniv 831 users)

On Jul, 18, 2016

47 people who take Cetirizine Hydrochloride Allergy, Intuniv are studied.


Number of reports submitted per year:

Cetirizine hydrochloride allergy and Intuniv drug interactions.

Drug effectiveness over time:

Cetirizine Hydrochloride Allergy:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 1 people)
Intuniv:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Cetirizine Hydrochloride Allergy:
  • female: 0.0% - (0 of 3 people)
  • male: 0.0% - (0 of 4 people)
Intuniv:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 5 people)

Drug effectiveness by age:

Cetirizine Hydrochloride Allergy:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 3 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Intuniv:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 2 people)
  • 10-19: 0.0% - (0 of 3 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • fatigue
  • anxiety
  • insomnia
  • negative thoughts
  • self-injurious ideation
  • tachyphrenia
  • violence-related symptom
  • abdominal pain upper
  • decreased appetite
  • head injury
1 - 6 months:
  • hyponatraemia
  • weakness
  • fatigue
  • headache
  • muscle fatigue
6 - 12 months:
  • appetite - decreased
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • growth retardation
  • lack of strength, muscle weakness, weakness
  • muscle twitching
  • sleep paralysis
1 - 2 years:
  • weight gain
  • depression
  • tinnitus
5 - 10 years:
  • depression
  • tinnitus
  • weight gain
10+ years:
  • hyponatraemia
  • weakness
  • fatigue
  • headache
  • muscle fatigue
not specified:
  • fatigue
  • anxiety
  • drug administration error
  • drug ineffective
  • mobility decreased
  • pain in extremity
  • depression
  • dizziness
  • hypotension
  • injury

Most common drug interactions by gender *:

female:
  • depression
  • mobility decreased
  • anxiety
  • fatigue
  • injury
  • oedema peripheral
  • blood creatinine increased
  • blood urea increased
  • dyspnoea
  • emotional distress
male:
  • fatigue
  • dizziness
  • anxiety
  • insomnia
  • negative thoughts
  • self-injurious ideation
  • tachyphrenia
  • violence-related symptom
  • hypoaesthesia
  • application site erythema

Most common drug interactions by age *:

2-9:
  • blood creatinine increased
  • blood urea increased
  • hypotension
  • pharyngitis streptococcal
  • pyrexia
  • renal failure acute
  • serum ferritin increased
  • urinary tract infection
  • urosepsis
  • vomiting
10-19:
  • anxiety
  • insomnia
  • negative thoughts
  • self-injurious ideation
  • tachyphrenia
  • violence-related symptom
  • drug administration error
  • drug ineffective
  • abnormal behaviour
  • appetite - decreased
20-29:
  • depression
  • tinnitus
  • weight gain
30-39:
  • hyponatraemia
  • weakness
  • fatigue
  • headache
  • muscle fatigue
40-49:
  • chills
  • dizziness
  • fatigue
  • hyperhidrosis
  • hypersomnia
  • lacrimation increased
  • lethargy
  • pain in extremity
  • pharyngolaryngeal pain
  • arthralgia
50-59:
  • anxiety
  • emotional distress
  • fibrosis
  • gait disturbance
  • general physical health deterioration
  • hyperaesthesia
  • joint range of motion decreased
  • mobility decreased
  • muscle tightness
  • nephrogenic systemic fibrosis
60+:
  • dyspnoea
  • injury
  • mobility decreased
  • nausea
  • abdominal pain
  • adrenal mass
  • anaemia
  • arterial occlusive disease
  • arthralgia
  • depression

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Cetirizine hydrochloride allergy and Intuniv?

Can you answer these questions?

More questions for: Cetirizine hydrochloride allergy, Intuniv

You may be interested in these reviews

More reviews for: Cetirizine hydrochloride allergy, Intuniv

On eHealthMe, Cetirizine hydrochloride allergy (cetirizine) is often used to treat allergies. Intuniv (guanfacine) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.